STOCK TITAN

Nu Skin Enter Stock Price, News & Analysis

NUS NYSE

Welcome to our dedicated page for Nu Skin Enter news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enter stock.

Nu Skin Enterprises Inc (NYSE: NUS) provides a centralized hub for tracking corporate developments across its global health, beauty, and wellness operations. This resource aggregates official press releases and verified news updates related to product innovations, financial performance, and strategic initiatives.

Investors and stakeholders gain immediate access to essential updates including quarterly earnings disclosures, manufacturing advancements through subsidiaries like Groviv and Wasatch Labs, and expansions of the company’s direct-selling network. All content is curated to support informed analysis of Nu Skin’s market position in the beauty and nutraceutical sectors.

The news collection features developments across three key areas: product launches in skincare and nutritional supplements, sustainability initiatives in automated agriculture technology, and financial disclosures reflecting global operations in 50+ countries. Additional coverage includes leadership updates and partnership announcements with digital platforms like Mavely.

Bookmark this page for streamlined monitoring of Nu Skin’s progress in merging scientific research with direct-selling expertise. Regular updates ensure timely awareness of material developments affecting the company’s NYSE-listed performance.

Rhea-AI Summary

NU Skin Enterprises (NYSE:NUS) received coverage initiation from Stonegate Capital Partners following strong Q2 2025 performance. The company reported revenue of $386.1M, reaching the high end of their guidance range of $355.0M-$390.0M.

Key highlights include adjusted EPS of $0.43, significantly exceeding guidance of $0.20-$0.30, and adjusted net income growth of 103.5% year-over-year. The company's gross margin expanded 106 basis points quarter-over-quarter to 68.8%. Notable segment performance included Rhyz Manufacturing's 17% revenue growth and Latin America's 107% revenue increase year-over-year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.48%
Tags
none
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE:NUS) reported Q2 2025 financial results with revenue of $386.1 million, at the high end of guidance despite a 12.1% year-over-year decline. The company achieved earnings per share of $0.43, exceeding forecasts and improving from $(2.38) in the prior year.

Key highlights include an 8% operating margin and strong performance in the Rhyz Manufacturing segment with 17% year-over-year growth. The company reached a positive net cash position for the first time in over 4 years. Nu Skin narrowed its 2025 revenue guidance to $1.48-$1.55 billion and raised EPS guidance to $3.05-$3.25.

Strategic initiatives include the upcoming Q4 preview of Prysm iO intelligent wellness device and planned expansion into India in 2026, building on success in Latin America where revenue grew 107% year-over-year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.43%
Tags
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE:NUS) has announced that its board of directors has declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on September 10, 2025, to shareholders of record as of August 29, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.43%
Tags
dividends
Rhea-AI Summary

Nu Skin Enterprises (NYSE:NUS) has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close. The company's management team will host a conference call with investors at 5 p.m. ET on the same day to discuss quarterly results and upcoming business initiatives.

The conference call webcast and financial information will be accessible through Nu Skin's investor relations website at ir.nuskin.com. A replay of the webcast will remain available until Thursday, August 21.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
-
Rhea-AI Summary

Nu Skin (NYSE: NUS) has announced a significant relaunch of its ageLOC® Tru Face® skincare line, focusing on sustainable packaging innovations while maintaining product efficacy. The initiative aims to save 515,000 pounds of glass and plastic and eliminate 572 tons of emissions annually by the end of 2025.

The refreshed line includes notable products such as the Transforming Gel Cream, showing 100% user satisfaction in hydration within two weeks, and the Refining Toner with up to 47% improvement in tone evenness. Key sustainability features include refillable systems, recycled materials usage, and innovative packaging solutions like the TFEU refill pouch that reduces material use by 96.8%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.1%
Tags
none
-
Rhea-AI Summary
Nu Skin Enterprises (NYSE: NUS) has appointed James Winett, managing member of SIZE Advisory Group, to its board of directors following a shareholder election. Winett brings significant expertise in strategic planning, operations, and finance from his consulting background. He co-founded SIZE Advisory Group in 2020, providing consulting services to companies of various sizes. His previous experience includes founding DPAA Group, Inc. (2014-2023) and working at Price Waterhouse LLP in audit, assurance, and corporate recovery roles. Winett holds an MBA from Northwestern University's Kellogg School of Management and a BS in Accountancy from the University of Illinois. The company expects his expertise to benefit both Nu Skin's main operations and its Rhyz businesses, particularly in corporate transactions and startup advisory.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.48%
Tags
management
Rhea-AI Summary
Nu Skin Enterprises (NUS) reported Q1 2025 revenue of $364.5 million, reaching the high end of guidance despite a 12.7% year-over-year decline. EPS was $2.14, or $0.23 excluding Mavely gain and other charges. The company saw growth in Latin America and Rhyz manufacturing but faced challenges in premium beauty due to inflation and tariffs. Key metrics showed declines with customers down 11%, paid affiliates down 15%, and sales leaders down 20%. The company reduced debt by $155 million, reaching its lowest level in 10 years. For Q2 2025, Nu Skin projects revenue of $355-390 million with EPS of $0.20-0.30. Full-year 2025 guidance maintained at $1.48-1.62 billion in revenue and EPS of $2.80-3.20 (or $0.90-1.30 excluding Mavely gain).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.04%
Tags
none
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) has announced that its board of directors has declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on June 11, 2025, to shareholders who are on record as of May 30, 2025. This dividend declaration represents the company's continued commitment to returning value to shareholders through regular dividend payments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.04%
Tags
dividends
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) has scheduled the release of its first quarter 2025 financial results after market close on Thursday, May 8. The company's management team will host a conference call with investors at 5 p.m. ET on the same day to discuss quarterly performance and upcoming business initiatives.

The financial presentation and conference call will be accessible via webcast on the company's investor relations website at ir.nuskin.com. A replay option will remain available through Thursday, May 22.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.21%
Tags
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) reported Q4 2024 revenue of $445.6 million, down 8.8% year-over-year but above company guidance, with a 4.1% FX impact. Q4 EPS was $(0.73), or $0.38 excluding restructuring charges. Full-year 2024 revenue reached $1.73 billion, declining 12% with a 3.8% FX impact.

The company's Rhyz segment showed strong growth, with Q4 revenue of $83.1 million (+27.7%) and full-year revenue of $286.6 million (+32.3%). Customer base decreased 15% to 831,972, with paid affiliates down 13% and sales leaders declining 16%.

For 2025, Nu Skin projects revenue between $1.48-$1.62 billion, expecting a 3% FX headwind. Q1 2025 revenue guidance is $345-365 million, with EPS forecast of $2.65-$2.75, or $0.10-$0.20 excluding the Mavely transaction gain.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.76%
Tags

FAQ

What is the current stock price of Nu Skin Enter (NUS)?

The current stock price of Nu Skin Enter (NUS) is $12.17 as of August 29, 2025.

What is the market cap of Nu Skin Enter (NUS)?

The market cap of Nu Skin Enter (NUS) is approximately 603.4M.
Nu Skin Enter

NYSE:NUS

NUS Rankings

NUS Stock Data

603.38M
47.11M
2.23%
74.85%
3.75%
Household & Personal Products
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
PROVO